This is the new cure medicine for Alzheimer's.

More recently, new developments have been noted in the treatment of Alzheimer's disease.

Donanemab, a drug taken in the form of transfusion, has been discovered to help slow down the ability to perform day - to - day activities. This is the main symptoms facing patients with Alzheimer's.

This drug is produced by American pharmaceutical firm Eli Lilly and is expected to publish the full results of the study by tomorrow.

This is the second drug that shows fine results in treating this disease. Nearly a year ago, the lecanemab was approved for use in America.
These developments have also been welcomed by the community of doctors who are focused on treating this disease.

After 20 years without new Alzheimer's treatment drugs, we already have 2 new treatments within 12 months that have the potential to treat this disease.” He spoke of The Mirror Richard Oakley, from “Alzheimer's Society”

Donanemab during the testing period has been given patients once a month through transfusions for an 18 - month period and has produced very satisfying results in treating this disease and its symptoms.

In the meantime, it is thought that a dose of this drug will cost about $1,600 for pacifists.

We remember that Alzheimer's disease is the main cause of the public. Demencia makes it difficult for patients to remember, think, and also prevent daily activities. As life expectancy has increased, the disease is considered one of the world's greatest health problems.